Multiple Myeloma Clinical Trial Closes Early Due to Significantly Superior Results of Comparative Treatment

Mayo Clinic Cancer Center announced today that a multiple myeloma clinical trial has shown a significant improvement in survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone.

External Link: http://www.mayoclinic.org/news2007-rst/3994.html